{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:26:18Z","timestamp":1759847178842},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T00:00:00Z","timestamp":1621468800000},"content-version":"vor","delay-in-days":2606,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.4103\/0255-0857.129804","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T08:24:33Z","timestamp":1396340673000},"page":"161-163","source":"Crossref","is-referenced-by-count":19,"title":["Revised ciprofloxacin breakpoints for Salmonella Typhi: Its implications in India"],"prefix":"10.1016","volume":"32","author":[{"given":"V","family":"Balaji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Kapil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4103\/0255-0857.129804_bib1","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1371\/journal.pone.0000542","article-title":"An open randomized comparison of gatifloxacin versus cefixime for the treatment of uncomplicated enteric fever","volume":"2","author":"Pandit","year":"2007","journal-title":"PLoS One"},{"key":"10.4103\/0255-0857.129804_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/44.2.243","article-title":"Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India","volume":"44","author":"Butler","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.4103\/0255-0857.129804_bib3","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1099\/jmm.0.47822-0","article-title":"Is nalidixic acid resistance linked to clinical virulence in Salmonella enterica serovar Typhi infections?","volume":"57","author":"Kadhiravan","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.4103\/0255-0857.129804_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2334-5-37","article-title":"Clinical outcomes in typhoid fever: Adverse impact of infection with nalidixic acid-resistant Salmonella Typhi","volume":"5","author":"Kadhiravan","year":"2005","journal-title":"BMC Infect Dis"},{"key":"10.4103\/0255-0857.129804_bib5","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twenty third Informational Supplement. CLSI document M100-23","first-page":"47","year":"2013"},{"key":"10.4103\/0255-0857.129804_bib6","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1469-0691.2011.03552.x","article-title":"Treatment of typhoid fever in the 21st century: Promises and shortcomings","volume":"17","author":"Butler","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.4103\/0255-0857.129804_bib7","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3201\/eid1607.091643","article-title":"ACC-1 beta-Lactamase-producing Salmonella enterica Serovar Typhi, India","volume":"16","author":"Gokul","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.4103\/0255-0857.129804_bib8","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1086\/317450","article-title":"Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children","volume":"31","author":"Frenck","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.4103\/0255-0857.129804_bib9","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/clinids\/21.4.1045","article-title":"Efficacy of azithromycin for typhoid fever","volume":"21","author":"Tribble","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.4103\/0255-0857.129804_bib10","first-page":"149","article-title":"Efficacy of azithromycin in the treatment of childhood typhoid fever","volume":"16","author":"Islam","year":"2007","journal-title":"Mymensingh Med J"},{"key":"10.4103\/0255-0857.129804_bib11","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1086\/382359","article-title":"Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents","volume":"38","author":"Frenck","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.4103\/0255-0857.129804_bib12","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1128\/AAC.44.7.1855-1859.2000","article-title":"A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever","volume":"44","author":"Chinh","year":"2000","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.4103\/0255-0857.129804_bib13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/AAC.00447-06","article-title":"Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin\u2013azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever","volume":"51","author":"Parry","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/0255-0857.129804_bib14","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/AAC.43.6.1441","article-title":"Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance","volume":"43","author":"Girgis","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.4103\/0255-0857.129804_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00006454-199903000-00007","article-title":"A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group","volume":"18","author":"Phuong","year":"1999","journal-title":"Pediatr Infect Dis J"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085721004941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085721004941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T13:25:04Z","timestamp":1621517104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085721004941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0255085721004941"],"URL":"https:\/\/doi.org\/10.4103\/0255-0857.129804","relation":{},"ISSN":["0255-0857"],"issn-type":[{"value":"0255-0857","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}